Array
(
[0] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1728374008:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => IV/IM Powder For Injection
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 1g
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 2g
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4667
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Cefoperz (Cefoperazone + Sulbactam) is indicated for the treatment of the following infections when caused by susceptible organisms.
- Respiratory tract infections (Upper and Lower)
- Urinary tract infections (Upper and Lower)
- Peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections
- Septicemia
- Meningitis
- Skins and soft tissue infections
- Bone and joint infections
- Pelvic inflammatory disease, endometritis, gonorrhea, and other infections of the genital tract
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefoperazone + Sulbactam
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 723
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4669
[ID] => 4669
[post_author] => 1
[post_content] => Cefoperz (Cefoperazone + Sulbactam) is indicated for the treatment of the following infections when caused by susceptible organisms.
- Respiratory tract infections (Upper and Lower)
- Urinary tract infections (Upper and Lower)
- Peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections
- Septicemia
- Meningitis
- Skins and soft tissue infections
- Bone and joint infections
- Pelvic inflammatory disease, endometritis, gonorrhea, and other infections of the genital tract
[post_date] => 2024-10-08 07:54:11
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Cefoperz™
[post_type] => product
[slug] => cefoperz
[__type:protected] =>
[_edit_lock] => 1728374008:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => IV/IM Powder For Injection
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 1g
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 2g
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4667
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Cefoperz (Cefoperazone + Sulbactam) is indicated for the treatment of the following infections when caused by susceptible organisms.
- Respiratory tract infections (Upper and Lower)
- Urinary tract infections (Upper and Lower)
- Peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections
- Septicemia
- Meningitis
- Skins and soft tissue infections
- Bone and joint infections
- Pelvic inflammatory disease, endometritis, gonorrhea, and other infections of the genital tract
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefoperazone + Sulbactam
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 723
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
[post_date_gmt] => 2024-10-08 07:54:11
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cefoperz
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-08 07:54:58
[post_modified_gmt] => 2024-10-08 07:54:58
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4669
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[1] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1729485869:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => DPI Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4666
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Vilanto-UF DPI Capsule is indicated:
• As a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist.
• For the maintenance treatment of asthma in patients aged 18 years and older
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Fluticasone Furoate + Umeclidinium + Vilanterol
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Respiratory system
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 727
[rank_math_primary_filters] => 75
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 2.5mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4662
[ID] => 4662
[post_author] => 1
[post_content] => Vilanto-UF DPI Capsule is indicated:
• As a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist.
• For the maintenance treatment of asthma in patients aged 18 years and older
[post_date] => 2024-10-08 07:45:38
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Vilanto™-UF
[post_type] => product
[slug] => vilanto-uf
[__type:protected] =>
[_edit_lock] => 1729485869:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => DPI Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4666
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Vilanto-UF DPI Capsule is indicated:
• As a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist.
• For the maintenance treatment of asthma in patients aged 18 years and older
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Fluticasone Furoate + Umeclidinium + Vilanterol
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Respiratory system
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 727
[rank_math_primary_filters] => 75
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 2.5mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[post_date_gmt] => 2024-10-08 07:45:38
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => vilanto-uf
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-21 04:46:42
[post_modified_gmt] => 2024-10-21 04:46:42
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4662
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[2] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1725625520:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4644
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Roxadustat is indicated for treatment of adult patients with symptomatic anemia associated with chronic kidney disease (CKD)
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Roxadustat
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Anemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 718
[rank_math_primary_filters] => 720
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 20MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 50MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 100MG
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4643
[ID] => 4643
[post_author] => 1
[post_content] => Roxadustat is indicated for treatment of adult patients with symptomatic anemia associated with chronic kidney disease (CKD)
[post_date] => 2024-09-06 12:19:00
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Roxaget™
[post_type] => product
[slug] => roxaget
[__type:protected] =>
[_edit_lock] => 1725625520:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4644
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Roxadustat is indicated for treatment of adult patients with symptomatic anemia associated with chronic kidney disease (CKD)
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Roxadustat
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Anemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 718
[rank_math_primary_filters] => 720
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 20MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 50MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 100MG
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[post_date_gmt] => 2024-09-06 12:19:00
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => roxaget
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-06 12:25:17
[post_modified_gmt] => 2024-09-06 12:25:17
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4643
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[3] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1725626517:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 4
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Tablet
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 15MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4642
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => - Adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers.
-Adults with active psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.
- Adults and pediatric patients 12 years of age and older with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies are inadvisable.
- Adult patients with moderately to severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers.
- Adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
- Adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more TNF blockers.
- Adults with active non-radiographic axial spondyloarthritis having objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal Anti-inflammatory drugs (NSAIDs)
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Upadacitinib
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => JAK inhibitors
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 450
[rank_math_primary_filters] => 21
[rank_math_primary_countries] => 40
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4637
[ID] => 4637
[post_author] => 1
[post_content] => - Adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers
- Adults with active psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers
- Adults and pediatric patients 12 years of age and older with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies are inadvisable
- Adult patients with moderately to severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers
- Adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent
- Adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more TNF blockers
- Adults with active non-radiographic axial spondyloarthritis having objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal Anti-inflammatory drugs (NSAIDs)
[post_date] => 2024-09-06 11:17:04
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Upaget™
[post_type] => product
[slug] => upaget
[__type:protected] =>
[_edit_lock] => 1725626517:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 4
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Tablet
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 15MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4642
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => - Adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers.
-Adults with active psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.
- Adults and pediatric patients 12 years of age and older with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies are inadvisable.
- Adult patients with moderately to severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers.
- Adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
- Adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more TNF blockers.
- Adults with active non-radiographic axial spondyloarthritis having objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal Anti-inflammatory drugs (NSAIDs)
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Upadacitinib
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => JAK inhibitors
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 450
[rank_math_primary_filters] => 21
[rank_math_primary_countries] => 40
[post_date_gmt] => 2024-09-06 11:17:04
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => upaget
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-06 12:33:35
[post_modified_gmt] => 2024-09-06 12:33:35
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4637
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[4] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1724415366:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 4
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4634
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] =>
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Empagliflozin + Linagliptin + Metformin HCl
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Diabetic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 35
[rank_math_primary_filters] => 21
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 5mg+2.5mg+1000mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 10mg+5mg+1000mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 12.5mg+2.5mg+1000mg
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_3_products_strengths] => 25mg+5mg+1000mg
[_getz_products_attributes_0_product_availability_3_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_3_product_link] =>
[_getz_products_attributes_0_product_availability_3_product_link] => field_5c0657259e1a3
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4632
[ID] => 4632
[post_author] => 1
[post_content] => Diampa LXR is a combination of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
[post_date] => 2024-08-23 11:10:55
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Diampa™ LXR
[post_type] => product
[slug] => diampa-lxr
[__type:protected] =>
[_edit_lock] => 1724415366:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 4
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4634
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] =>
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Empagliflozin + Linagliptin + Metformin HCl
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Diabetic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 35
[rank_math_primary_filters] => 21
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 5mg+2.5mg+1000mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 10mg+5mg+1000mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 12.5mg+2.5mg+1000mg
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_3_products_strengths] => 25mg+5mg+1000mg
[_getz_products_attributes_0_product_availability_3_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_3_product_link] =>
[_getz_products_attributes_0_product_availability_3_product_link] => field_5c0657259e1a3
[post_date_gmt] => 2024-08-23 11:10:55
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => diampa-lxr
[to_ping] =>
[pinged] =>
[post_modified] => 2024-08-23 12:01:01
[post_modified_gmt] => 2024-08-23 12:01:01
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4632
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[5] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1719406135:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 3
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4624
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Xifarox (Cefadroxil) is indicated for the treatment of following infections caused by cefadroxil-susceptible organisms, when an oral therapy is indicated:
- Streptococcal pharyngitis and tonsillitis
- Bronchopneumonia, bacterial pneumonia
- Urinary tract infections: pyelonephritis, cystitis
- Skin and soft tissue infections: abscesses, furunculosis, impetigo, erysipelas, pyoderma, lymphadenitis
- Other Infections: Osteomyelitis and septic arthritis
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefadroxil
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 140
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_type] => Suspension
[_getz_products_attributes_1_product_type] => field_57aacd67c871f
[getz_products_attributes_1_product_availability_0_products_strengths] => 250mg/5ml
[_getz_products_attributes_1_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_0_product_link] =>
[_getz_products_attributes_1_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability_1_products_strengths] => 125MG/5ML
[_getz_products_attributes_1_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_1_product_link] =>
[_getz_products_attributes_1_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability] => 2
[_getz_products_attributes_1_product_availability] => field_57aacbc108025
[getz_products_attributes_2_product_type] => Drops
[_getz_products_attributes_2_product_type] => field_57aacd67c871f
[getz_products_attributes_2_product_availability_0_products_strengths] => 100mg/ml
[_getz_products_attributes_2_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_2_product_availability_0_product_link] =>
[_getz_products_attributes_2_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_2_product_availability] => 1
[_getz_products_attributes_2_product_availability] => field_57aacbc108025
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4622
[ID] => 4622
[post_author] => 1
[post_content] => Xifarox (Cefadroxil) is indicated for the treatment of following infections caused by cefadroxil-susceptible organisms, when an oral therapy is indicated:
- Streptococcal pharyngitis and tonsillitis
- Bronchopneumonia, bacterial pneumonia
- Urinary tract infections: pyelonephritis, cystitis
- Skin and soft tissue infections: abscesses, furunculosis, impetigo, erysipelas, pyoderma, lymphadenitis
- Other Infections: Osteomyelitis and septic arthritis
[post_date] => 2024-06-26 11:38:41
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Xifarox™
[post_type] => product
[slug] => xifarox
[__type:protected] =>
[_edit_lock] => 1719406135:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 3
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4624
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Xifarox (Cefadroxil) is indicated for the treatment of following infections caused by cefadroxil-susceptible organisms, when an oral therapy is indicated:
- Streptococcal pharyngitis and tonsillitis
- Bronchopneumonia, bacterial pneumonia
- Urinary tract infections: pyelonephritis, cystitis
- Skin and soft tissue infections: abscesses, furunculosis, impetigo, erysipelas, pyoderma, lymphadenitis
- Other Infections: Osteomyelitis and septic arthritis
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefadroxil
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 140
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_type] => Suspension
[_getz_products_attributes_1_product_type] => field_57aacd67c871f
[getz_products_attributes_1_product_availability_0_products_strengths] => 250mg/5ml
[_getz_products_attributes_1_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_0_product_link] =>
[_getz_products_attributes_1_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability_1_products_strengths] => 125MG/5ML
[_getz_products_attributes_1_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_1_product_link] =>
[_getz_products_attributes_1_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability] => 2
[_getz_products_attributes_1_product_availability] => field_57aacbc108025
[getz_products_attributes_2_product_type] => Drops
[_getz_products_attributes_2_product_type] => field_57aacd67c871f
[getz_products_attributes_2_product_availability_0_products_strengths] => 100mg/ml
[_getz_products_attributes_2_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_2_product_availability_0_product_link] =>
[_getz_products_attributes_2_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_2_product_availability] => 1
[_getz_products_attributes_2_product_availability] => field_57aacbc108025
[post_date_gmt] => 2024-06-26 11:38:41
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => xifarox
[to_ping] =>
[pinged] =>
[post_modified] => 2024-06-26 12:43:52
[post_modified_gmt] => 2024-06-26 12:43:52
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4622
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[6] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1719401929:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 3
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4621
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Cefaloget is indicated for the treatment of the following infections due to susceptible microorganisms:
- Respiratory tract infections, including pneumonia, bronchitis, exacerbations of chronic bronchitis, pharyngitis and tonsillitis
- Sinusitis
- Otitis media
- Skin and soft tissue infections
- Urinary tract infections, including pyelonephritis and cystitis
- Gonococcal urethritis
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefaclor
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 713
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 250MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_type] => Powder for Oral Suspension
[_getz_products_attributes_1_product_type] => field_57aacd67c871f
[getz_products_attributes_1_product_availability_0_products_strengths] => 125MG/5ML
[_getz_products_attributes_1_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_0_product_link] =>
[_getz_products_attributes_1_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability_1_products_strengths] => 200MG/5ML
[_getz_products_attributes_1_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_1_product_link] =>
[_getz_products_attributes_1_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability] => 2
[_getz_products_attributes_1_product_availability] => field_57aacbc108025
[getz_products_attributes_2_product_type] => Drops
[_getz_products_attributes_2_product_type] => field_57aacd67c871f
[getz_products_attributes_2_product_availability_0_products_strengths] => 50mg/ml
[_getz_products_attributes_2_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_2_product_availability_0_product_link] =>
[_getz_products_attributes_2_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_2_product_availability] => 1
[_getz_products_attributes_2_product_availability] => field_57aacbc108025
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4620
[ID] => 4620
[post_author] => 1
[post_content] => Cefaloget is indicated for the treatment of the following infections due to susceptible microorganisms:
- Respiratory tract infections, including pneumonia, bronchitis, exacerbations of chronic bronchitis, pharyngitis and tonsillitis
- Sinusitis
- Otitis media
- Skin and soft tissue infections
- Urinary tract infections, including pyelonephritis and cystitis
- Gonococcal urethritis
[post_date] => 2024-06-26 07:55:24
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Cefaloget™
[post_type] => product
[slug] => cefaloget
[__type:protected] =>
[_edit_lock] => 1719401929:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 3
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4621
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Cefaloget is indicated for the treatment of the following infections due to susceptible microorganisms:
- Respiratory tract infections, including pneumonia, bronchitis, exacerbations of chronic bronchitis, pharyngitis and tonsillitis
- Sinusitis
- Otitis media
- Skin and soft tissue infections
- Urinary tract infections, including pyelonephritis and cystitis
- Gonococcal urethritis
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefaclor
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 713
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 250MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_type] => Powder for Oral Suspension
[_getz_products_attributes_1_product_type] => field_57aacd67c871f
[getz_products_attributes_1_product_availability_0_products_strengths] => 125MG/5ML
[_getz_products_attributes_1_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_0_product_link] =>
[_getz_products_attributes_1_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability_1_products_strengths] => 200MG/5ML
[_getz_products_attributes_1_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_1_product_availability_1_product_link] =>
[_getz_products_attributes_1_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_1_product_availability] => 2
[_getz_products_attributes_1_product_availability] => field_57aacbc108025
[getz_products_attributes_2_product_type] => Drops
[_getz_products_attributes_2_product_type] => field_57aacd67c871f
[getz_products_attributes_2_product_availability_0_products_strengths] => 50mg/ml
[_getz_products_attributes_2_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_2_product_availability_0_product_link] =>
[_getz_products_attributes_2_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_2_product_availability] => 1
[_getz_products_attributes_2_product_availability] => field_57aacbc108025
[post_date_gmt] => 2024-06-26 07:55:24
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cefaloget
[to_ping] =>
[pinged] =>
[post_modified] => 2024-06-26 11:40:34
[post_modified_gmt] => 2024-06-26 11:40:34
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4620
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[7] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1719984977:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Injection
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4617
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Cefepime is indicated in the treatment of the following infections caused by bacteria that are Cefepime-sensitive:
Lower respiratory tract infection, uncomplicated and complicated urinary tract infections, skin and subcutaneous infections, intra-abdominal infections, gynecological infections, bacterial meningitis in infants and children.
In combination with other antibacterial agents in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefepime
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 140
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 1000mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4616
[ID] => 4616
[post_author] => 1
[post_content] => Cefepime is indicated in the treatment of the following infections caused by bacteria that are Cefepime-sensitive:
Lower respiratory tract infection, uncomplicated and complicated urinary tract infections, skin and subcutaneous infections, intra-abdominal infections, gynecological infections, bacterial meningitis in infants and children.
In combination with other antibacterial agents in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
[post_date] => 2024-06-26 07:31:15
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Fectopime™
[post_type] => product
[slug] => fectopime
[__type:protected] =>
[_edit_lock] => 1719984977:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Injection
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4617
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Cefepime is indicated in the treatment of the following infections caused by bacteria that are Cefepime-sensitive:
Lower respiratory tract infection, uncomplicated and complicated urinary tract infections, skin and subcutaneous infections, intra-abdominal infections, gynecological infections, bacterial meningitis in infants and children.
In combination with other antibacterial agents in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefepime
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 140
[rank_math_primary_filters] => 74
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 1000mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[post_date_gmt] => 2024-06-26 07:31:15
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => fectopime
[to_ping] =>
[pinged] =>
[post_modified] => 2024-07-01 10:52:24
[post_modified_gmt] => 2024-07-01 10:52:24
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4616
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[8] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1719402042:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => IV/IM Injection
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4614
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Ximatof (Cefotaxime) is indicated for the treatment of the following infections due to susceptible microorganisms:
- Respiratory tract infections
- Genitourinary infections
- Gynecologic infections
- Bacteremia/Septicemia
- Skin and skin structure infections
- Intra-abdominal infections
- Lyme-borreliosis (especially stages II and III)
- Bone and/or joint infections
- Central nervous system infections
- Endocarditis
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefotaxime
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 660
[rank_math_primary_filters] => 92
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 250MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 1g
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4613
[ID] => 4613
[post_author] => 1
[post_content] => Ximatof (Cefotaxime) is indicated for the treatment of the following infections due to susceptible microorganisms:
- Respiratory tract infections
- Genitourinary infections
- Gynecologic infections
- Bacteremia/Septicemia
- Skin and skin structure infections
- Intra-abdominal infections
- Lyme-borreliosis (especially stages II and III)
- Bone and/or joint infections
- Central nervous system infections
- Endocarditis
[post_date] => 2024-06-26 07:21:19
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Ximatof™
[post_type] => product
[slug] => ximatof
[__type:protected] =>
[_edit_lock] => 1719402042:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => IV/IM Injection
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4614
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Ximatof (Cefotaxime) is indicated for the treatment of the following infections due to susceptible microorganisms:
- Respiratory tract infections
- Genitourinary infections
- Gynecologic infections
- Bacteremia/Septicemia
- Skin and skin structure infections
- Intra-abdominal infections
- Lyme-borreliosis (especially stages II and III)
- Bone and/or joint infections
- Central nervous system infections
- Endocarditis
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Cefotaxime
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antibiotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 660
[rank_math_primary_filters] => 92
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_availability_0_products_strengths] => 250MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 500MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 1g
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[post_date_gmt] => 2024-06-26 07:21:19
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => ximatof
[to_ping] =>
[pinged] =>
[post_modified] => 2024-06-26 07:46:30
[post_modified_gmt] => 2024-06-26 07:46:30
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4613
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[9] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1716208208:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Disposable pen (3ml)
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 100IU/ML
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4555
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Long acting (basal) insulin indicated to improve glycemic control in adult & pediatric patients with type 1 diabetes mellitus and adult patients with type 2 diabetes mellitus. It is available as a 3ml pre-filled pen and given by a daily subcutaneous injection.
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Insulin Glargine
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Diabetic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 143
[rank_math_primary_filters] => 60
[rank_math_primary_countries] => 40
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4559
[ID] => 4559
[post_author] => 1
[post_content] => Long acting (basal) insulin indicated to improve glycemic control in adult & pediatric patients with type 1 diabetes mellitus and adult patients with type 2 diabetes mellitus. It is available as a 3ml pre-filled pen and given by a daily subcutaneous injection.
[post_date] => 2024-05-20 12:20:17
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Basagine™ Pen
[post_type] => product
[slug] => basagine-pen
[__type:protected] =>
[_edit_lock] => 1716208208:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[attributes] =>
[_attributes] => field_57879498f70b4
[getz_products_attributes_0_product_type] => Disposable pen (3ml)
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 100IU/ML
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 1
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4555
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Long acting (basal) insulin indicated to improve glycemic control in adult & pediatric patients with type 1 diabetes mellitus and adult patients with type 2 diabetes mellitus. It is available as a 3ml pre-filled pen and given by a daily subcutaneous injection.
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[generic_name] => Insulin Glargine
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Diabetic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 143
[rank_math_primary_filters] => 60
[rank_math_primary_countries] => 40
[post_date_gmt] => 2024-05-20 12:20:17
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => basagine-pen
[to_ping] =>
[pinged] =>
[post_modified] => 2024-05-20 12:31:36
[post_modified_gmt] => 2024-05-20 12:31:36
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4559
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
)